Sees FY26 adjusted EBITDA $250M-$280M.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ASTH:
- Astrana Health reports Q4 adjusted EPS 54c, consensus 33c
- Astrana Health Inc. (ASTH) Q4 Earnings Cheat Sheet
- Astrana Health price target lowered to $40 from $45 at BTIG
- Astrana Health: Market Overreaction to CMS Risk-Adjustment Proposal Creates a Buy Opportunity
- Astrana Health Updates Investor Presentation Highlighting National Expansion